Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
KR |
|
Brambles Ltd
ASX:BXB
|
AU |
|
O
|
Otello Corporation ASA
XMUN:OS3
|
NO |
|
C29 Metals Ltd
F:OF0
|
AU |
|
L
|
Louisiana-Pacific Corp
F:LP3
|
US |
|
V
|
VietinBank Securities JSC
VN:CTS
|
VN |
|
B
|
Brown & Brown Inc
F:BTW
|
US |
|
E
|
Euroapi SAS
OTC:EAPIF
|
FR |
|
A
|
Altair Resources Inc
F:90AA
|
CA |
Intrinsic Value
Is Sam Chun Dang Pharm Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Sam Chun Dang Pharm Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Sam Chun Dang Pharm Co Ltd looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with Sam Chun Dang Pharm Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Sam Chun Dang Pharm Does
Sam Chun Dang Pharm Co Ltd is a South Korean pharmaceutical company that develops, manufactures, and sells prescription medicines and over-the-counter drugs. Its product lineup includes hospital and clinic medicines as well as consumer health products, with a strong focus on medicines used in treatment areas such as eye care and other common therapies. The company sells these products to hospitals, clinics, pharmacies, and other drug distributors.
- Headquarters
- Korea KR
- Employees
- 422
- IPO date
- Oct 4, 2000
Revenue & Expenses Breakdown
Sam Chun Dang Pharm Co Ltd
Earnings Waterfall
Sam Chun Dang Pharm Co Ltd
The intrinsic value for Sam Chun Dang Pharm Co Ltd (000250) under the Base Case is hidden KRW.
Compared with the current market price of 199 200 KRW, the stock appears hidden.